Genomic Expression is finding the best drug for the patient and the best patient for the drug by sequencing RNA. Analyzing RNA is able to tell if the tumor will respond to the new immune therapies, which is the only kind of therapy that is a potential cure.
Our OneRNA platform can be applied from design of trial to analyzing the patients and stratify them into the arms of such a trial.